Dynamic monitoring of serum soluble programmed cell death ligand 1 as a response predictor to chemotherapy in metastatic or recurrent gastrointestinal cancer

BACKGROUND: Biomarkers in serum may have important clinical implications for personalized medicine, including therapeutic guidance, and monitoring of recurrence. The role of programmed cell death ligand 1 (PD-L1) expression as a tumor biomarker remains controversial. In this study, we aimed at deter...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jin, Qiu, Miao-Zhen, Mei, Ting, Gao, Yuan, Chang, Boyang, Zhang, Yuxin, Wang, Feng-Hua, Li, Su
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798804/
https://www.ncbi.nlm.nih.gov/pubmed/35117603
http://dx.doi.org/10.21037/tcr.2020.03.23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798804/
https://www.ncbi.nlm.nih.gov/pubmed/35117603
http://dx.doi.org/10.21037/tcr.2020.03.23

Ejemplares similares